MacroGenics
MGNX
#9452
Rank
โ‚น11.60 B
Marketcap
โ‚น181.63
Share price
-1.01%
Change (1 day)
44.22%
Change (1 year)

Market capitalization of MacroGenics (MGNX)

Market cap: โ‚น11.60 Billion

As of November 2026 MacroGenics has a market cap of โ‚น11.60 Billion. This makes MacroGenics the world's 9452th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of MacroGenics from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น11.60 B26.96%
2025โ‚น9.14 B-47.43%
2024โ‚น17.39 B-64.99%
2023โ‚น49.67 B45.53%
2022โ‚น34.13 B-53.39%
2021โ‚น73.23 B-22.11%
2020โ‚น94.03 B

End of Day market cap according to different sources

On Nov 20th, 2026 the market cap of MacroGenics was reported to be:

โ‚น11.60 Billion
by Nasdaq info icon info icon
โ‚น11.60 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
โ‚น14.472 T 124,579.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น111.197 T 957,840.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น21.837 T 188,020.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น19.129 T 164,698.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น30.548 T 263,071.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น11.138 T 95,853.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
โ‚น231.28 B 1,892.49%๐Ÿ‡บ๐Ÿ‡ธ USA